Rhone Ma Holdings Bhd (XKLS:5278) ROCE %: 9.39% (As of Mar. 2026)


XKLS:5278 Rhone Ma Holdings Bhd XKLS:5278
61 GF Score
Price RM0.69
GF Value RM0.80
Valuation Modestly Undervalued
View Full Analysis

What is Rhone Ma Holdings Bhd ROCE %?

Rhone Ma Holdings Bhd XKLS:5278 61 ROCE % is 9.39% as of Mar. 2026. GuruFocus rates XKLS:5278 with a GF Score™ of 61/100 and a GF Value™ of RM0.80 (Modestly Undervalued).

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Rhone Ma Holdings Bhd's annualized ROCE % for the quarter that ended in Mar. 2026 was 9.39%.

Rhone Ma Holdings Bhd  (XKLS:5278) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Rhone Ma Holdings Bhd ROCE % Related Terms

Rhone Ma Holdings Bhd ROCE % Historical Data

* Premium members only.

The historical data trend for Rhone Ma Holdings Bhd's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rhone Ma Holdings Bhd ROCE % Chart

Rhone Ma Holdings Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.47 11.54 10.54 10.22 10.79

Rhone Ma Holdings Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.31 10.76 10.90 13.75 9.39
XKLS:5278
61GF Score
Rhone Ma Holdings Bhd XKLS:5278
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rhone Ma Holdings Bhd ROCE % Calculation

Rhone Ma Holdings Bhd's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=21.967/( ( (225.237 - 24.278) + (258.487 - 52.17) )/ 2 )
=21.967/( (200.959+206.317)/ 2 )
=21.967/203.638
=10.79 %

Rhone Ma Holdings Bhd's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=19.544/( ( (258.487 - 52.17) + (246.005 - 36.057) )/ 2 )
=19.544/( ( 206.317 + 209.948 )/ 2 )
=19.544/208.1325
=9.39 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 9.39% mean?
Rhone Ma Holdings Bhd (XKLS:5278) has a ROCE % of 9.39% as of Mar. 2026.
Is Rhone Ma Holdings Bhd's ROCE % too high?
Rhone Ma Holdings Bhd's current ROCE % is 9.39%. The Drug Manufacturers industry median ROCE % is 7.03. Rhone Ma Holdings Bhd's value of 9.39% is 33.6% above this industry median. Overall, Rhone Ma Holdings Bhd has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rhone Ma Holdings Bhd's ROCE % compare to ZTS and UTHR?
Rhone Ma Holdings Bhd's ROCE % of 9.39% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.03. Rhone Ma Holdings Bhd's value of 9.39% is 33.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.03, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rhone Ma Holdings Bhd's current ROCE % of 9.39% is 33.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rhone Ma Holdings Bhd's current ROCE % is 9.39%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhone Ma Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Rhone Ma Holdings Bhd (XKLS:5278) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.80, compared to a current price of RM0.69 — trading 13.8% below its estimated fair value. The current ROCE % is 9.39% and 33.6% above the Drug Manufacturers industry median of 7.03. Rhone Ma Holdings Bhd's overall GF Score™ is 61/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Rhone Ma Holdings Bhd (XKLS:5278), the current ROCE % is 9.39% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rhone Ma Holdings Bhd (XKLS:5278) Overvalued in 2026?

Based on GuruFocus' analysis, Rhone Ma Holdings Bhd stock appears to be undervalued. The current stock price of RM0.69 is trading 13.8% below its estimated GF Value™ of RM0.80. GuruFocus considers Rhone Ma Holdings Bhd to be Modestly Undervalued.

Key valuation signals for XKLS:5278:

  • ROCE %: 9.39%
  • GF Value™: RM0.80 vs. price of RM0.69 (13.8% below fair value)
  • GF Score™: 61/100
  • Industry Position: 33.6% above the Drug Manufacturers median

No single metric tells the full story. See the XKLS:5278 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rhone Ma Holdings Bhd Business Description

Address Jalan 241, Lot 18A and 18B, Seksyen 51A, Petaling Jaya, SGR, MYS, 46100
Rhone Ma Holdings Bhd, along with its subsidiaries, is mainly involved in the provision of end-to-end animal health solutions. The Group provides veterinary consultation services, diagnostic laboratory analyses, R&D, and is engaged in the manufacturing and distribution of animal health products. Its reportable segments are: Animal health products and equipment, Food ingredients, and Others. The majority of its revenue is generated from the Animal health products and equipment segment, which is engaged in marketing, trading, distribution, and manufacturing of animal health products and equipment, such as pharmaceuticals, vaccines, feed additives, pesticides, and others. Geographically, the Group's operations are predominantly located in Malaysia.
61GF Score

Get the complete analysis for XKLS:5278

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.69
Price
RM0.80
GF Value